STAT NEWS
In Generic Drug Plants In China And India, Data Falsification Is Still A Problem.

READ

BLOOMBERG BUSINESSWEEK
Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.

READ

THE NEW YORKER
The Birth-Tissue Profiteers

READ

REGULATORY FOCUS
Scope of FDA Draft Guidance on Nonbinding Feedback is Too Restrictive, Industry Argues

READ

MEDSCAPE
‘Scary World’ of Generic Drug Manufacturing, Revealed

READ

THE WALL STREET JOURNAL 
Open-Government Laws Fuel Hedge-Fund Profits
Hedge Funds Are Using FOIA Requests to Obtain Nonpublic Information From Federal Agencies

READ

BOTTLE OF LIES
The Inside Story of the Generic Drug Boom

READ

BLOOMBERG QUINT
Trouble Mounts For Biocon’s Bengaluru Plant

READ

Press Releases

Check our Press section for the latest press releases.